Skip to Main Content

Author Details

Eugene I Hwang
Children's National Hospital. Electronic address: .
2004
57
25
PMIDPaper TitleJournal TitlePublished Year
37171383Addendum: Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report.Oncotarget2023
37160547Cellular Therapy for Children with Central Nervous System Tumors: Mining and Mapping the Correlative Data.Curr Oncol Rep2023
36944298Why haven't we solved intracranial pediatric ependymoma? Current questions and barriers to treatment advances.Neoplasia2023
37171383Addendum: Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report.Oncotarget2023
37160547Cellular Therapy for Children with Central Nervous System Tumors: Mining and Mapping the Correlative Data.Curr Oncol Rep2023
36944298Why haven't we solved intracranial pediatric ependymoma? Current questions and barriers to treatment advances.Neoplasia2023
35196386Two clinically distinct cases of infant hemispheric glioma carrying ZCCHC8:ROS1 fusion and responding to entrectinib.Neuro Oncol2022
36072789Safety of Tumor Treating Fields (TTFields) therapy in pediatric patients with malignant brain tumors: Post-marketing surveillance data.Front Oncol2022
35664557Pediatric pineoblastoma: A pooled outcome study of North American and Australian therapeutic data.Neurooncol Adv2022
36381305Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β.Mol Ther Methods Clin Dev2022
35121998The current landscape of immunotherapy for pediatric brain tumors.Nat Cancer2022
35196386Two clinically distinct cases of infant hemispheric glioma carrying ZCCHC8:ROS1 fusion and responding to entrectinib.Neuro Oncol2022
35664557Pediatric pineoblastoma: A pooled outcome study of North American and Australian therapeutic data.Neurooncol Adv2022
36072789Safety of Tumor Treating Fields (TTFields) therapy in pediatric patients with malignant brain tumors: Post-marketing surveillance data.Front Oncol2022
36381305Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β.Mol Ther Methods Clin Dev2022
35121998The current landscape of immunotherapy for pediatric brain tumors.Nat Cancer2022
33025730Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial.Pediatr Blood Cancer2021
34292305Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group.JAMA Oncol2021
34077956Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study.Neuro Oncol2021
33738452The experience of successful treatment of <i>ETV6-NTRK3</i>-positive infant glioblastoma with entrectinib.Neurooncol Adv2021
33547201A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study.Clin Cancer Res2021
33025730Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial.Pediatr Blood Cancer2021
33225764Considerations when treating high-grade pediatric glioma patients with immunotherapy.Expert Rev Neurother2021
33405376A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042).Pediatr Blood Cancer2021
33547201A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study.Clin Cancer Res2021
33738452The experience of successful treatment of <i>ETV6-NTRK3</i>-positive infant glioblastoma with entrectinib.Neurooncol Adv2021
34077956Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study.Neuro Oncol2021
34292305Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group.JAMA Oncol2021
33405376A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042).Pediatr Blood Cancer2021
33225764Considerations when treating high-grade pediatric glioma patients with immunotherapy.Expert Rev Neurother2021
32113728Immunotherapy Approaches for Pediatric CNS Tumors and Associated Neurotoxicity.Pediatr Neurol2020
31749132Molecularly Targeted Agents in the Therapy of Pediatric Brain Tumors.Paediatr Drugs2020
32113728Immunotherapy Approaches for Pediatric CNS Tumors and Associated Neurotoxicity.Pediatr Neurol2020
32055852Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference.Neuro Oncol2020
31763674οNp73/ETS2 complex drives glioblastoma pathogenesis- targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma.Neuro Oncol2020
32841504Pediatric diffuse leptomeningeal glioneuronal tumor: Two clinical cases of successful targeted therapy.Pediatr Blood Cancer2020
32055852Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference.Neuro Oncol2020
31749132Molecularly Targeted Agents in the Therapy of Pediatric Brain Tumors.Paediatr Drugs2020
31763674οNp73/ETS2 complex drives glioblastoma pathogenesis- targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma.Neuro Oncol2020
32841504Pediatric diffuse leptomeningeal glioneuronal tumor: Two clinical cases of successful targeted therapy.Pediatr Blood Cancer2020
30990879Differential Expression of Wilms' Tumor Protein in Diffuse Intrinsic Pontine Glioma.J Neuropathol Exp Neurol2019
30990879Differential Expression of Wilms' Tumor Protein in Diffuse Intrinsic Pontine Glioma.J Neuropathol Exp Neurol2019
31547819Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization.J Transl Med2019
31547819Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization.J Transl Med2019
29090526A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas.Pediatr Blood Cancer2018
30019219Heterogeneity within the PF-EPN-B ependymoma subgroup.Acta Neuropathol2018
30332335Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial.J Clin Oncol2018
30322880Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy.Clin Cancer Res2018
29090526A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas.Pediatr Blood Cancer2018
29472691A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy.Cell Res2018
  • 1 - 50 of 114

Recommended Authors

German Cancer Research Center (DKFZ)
Career Start Year 2017
Number of shared co-authors 14
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2016
Number of shared co-authors 37
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Children's Hospital Los Angeles
Career Start Year 2014
Number of shared co-authors 18
Nationwide Children's Hospital and The Ohio State University
Career Start Year 2013
Number of shared co-authors 17
Hopital Universitaire Necker-Enfants Malades
Career Start Year 2012
Number of shared co-authors 22
Washington University
Career Start Year 2012
Number of shared co-authors 36
Institute for Genomic Medicine, Nationwide Children's Hospital
Career Start Year 2011
Number of shared co-authors 0
University of Michigan-Ann Arbor
Career Start Year 2010
Number of shared co-authors 47
University of California
Career Start Year 2010
Number of shared co-authors 5
Oregon Health & Science University
Career Start Year 2007
Number of shared co-authors 29
Stanford University
Career Start Year 2006
Number of shared co-authors 52
MacKay Memorial Hospital
Career Start Year 2003
Number of shared co-authors 17
University of Toronto
Career Start Year 2003
Number of shared co-authors 64
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 2002
Number of shared co-authors 15
McMaster University
Career Start Year 2001
Number of shared co-authors 33
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 62
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 1998
Number of shared co-authors 79
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 1998
Number of shared co-authors 15
Center for Cancer and Blood Disorders, Children's Hospital Colorado.
Career Start Year 1997
Number of shared co-authors 62
Princess Margaret Cancer Centre
Career Start Year 1996
Number of shared co-authors 20
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 6
Brigham and Women's Hospital
Career Start Year 1996
Number of shared co-authors 23
NYU Grossman School of Medicine
Career Start Year 1995
Number of shared co-authors 14
Children's Hospitals and Clinics of Minnesota
Career Start Year 1993
Number of shared co-authors 75
Meyer Cancer Center
Career Start Year 1990
Number of shared co-authors 6
Institut Curie and University Paris Cite
Career Start Year 1987
Number of shared co-authors 70
Saitama Medical University International Medical Center
Career Start Year 1986
Number of shared co-authors 17
University of California san francisco
Career Start Year 1985
Number of shared co-authors 79
DOPO Clinic and Neuroncology Unit, IRCCS Istituto Giannina Gaslini (IGG)
Career Start Year 1983
Number of shared co-authors 65

Collaborators

Brain Tumor Institute, Children's National Hospital
Co-authored papers 24
Co-authored papers 11
The Hospital for Sick Children
Co-authored papers 10
St. Jude Children's Research Hospital
Co-authored papers 9
USA University of Zurich
Co-authored papers 9
The Hospital for Sick Children
Co-authored papers 8
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 8
Co-authored papers 7
Children's National Hospital
Co-authored papers 7
Co-authored papers 6
The Hospital for Sick Children
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Hospital for Sick Children
Co-authored papers 6
Co-authored papers 5
St. Jude Children's Research Hospital
Co-authored papers 5
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 5
St Jude Children's Research Hospital
Co-authored papers 5
Co-authored papers 5
Brain Tumor Institute, Children's National Hospital
Co-authored papers 5
Fondazione IRCCS Istituto Nazionale dei Tumori
Co-authored papers 5
University Children's Hospital Zurich
Co-authored papers 5
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 4
University Medical Center Hamburg-Eppendorf
Co-authored papers 4
The Hospital for Sick Children, University of Toronto
Co-authored papers 4